MEDPACE HOLDINGS INC (MEDP) Stock Price, Forecast & Analysis
NASDAQ:MEDP • US58506Q1094
MEDP Key Statistics, Chart & Performance
The current stock price of MEDP is 428.03 USD. In the past month the price decreased by -30.74%. In the past year, price increased by 25.83%.
MEDP Technical Analysis
MEDP Fundamental Analysis
ChartMill assigns a fundamental rating of 7 / 10 to MEDP. Both the health and profitability get an excellent rating, making MEDP a very profitable company, without any liquidiy or solvency issues.
MEDP Financial Highlights
Over the last trailing twelve months MEDP reported a non-GAAP Earnings per Share(EPS) of 15.3. The EPS increased by 21.14% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 17.83% | ||
| ROA | 22.84% | ||
| ROE | 98.27% | ||
| Debt/Equity | 0 |
MEDP Forecast & Estimates
18 analysts have analysed MEDP and the average price target is 557.47 USD. This implies a price increase of 30.24% is expected in the next year compared to the current price of 428.03.
For the next year, analysts expect an EPS growth of 9.87% and a revenue growth 11.71% for MEDP
MEDP Ownership
MEDP Latest News, Press Relases and Analysis
MEDP Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| TMO | THERMO FISHER SCIENTIFIC INC | 20.34 | 189.666B | ||
| DHR | DANAHER CORP | 25.03 | 150.273B | ||
| BRKRP | BRUKER CORP - BRKR 6 3/8 09/01/28 | 133.24 | 44.271B | ||
| A | AGILENT TECHNOLOGIES INC | 20.78 | 35.584B | ||
| IQV | IQVIA HOLDINGS INC | 12.76 | 28.313B | ||
| MTD | METTLER-TOLEDO INTERNATIONAL | 29.44 | 27.668B | ||
| WAT | WATERS CORP | 22.35 | 19.25B | ||
| WST | WEST PHARMACEUTICAL SERVICES | 31.91 | 18.02B | ||
| ILMN | ILLUMINA INC | 22.56 | 17.849B |
Related stock screener links
View all stocks in the Life Sciences Tools & Services Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find more growth stocks the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About MEDP
Company Profile
Medpace Holdings, Inc. engages in the provision of outsourced clinical development services to the biotechnology, pharmaceutical, and medical device industries. The company is headquartered in Cincinnati, Ohio and currently employs 5,900 full-time employees. The company went IPO on 2016-08-11. The firm partners with pharmaceutical, biotechnology, and medical device companies in the development and execution of clinical trials. The Company’s drug development services focus on full-service Phase I-IV clinical development services and include development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support. The firm also provides bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. The Company’s operations are principally based in North America, Europe, and Asia.
Company Info
MEDPACE HOLDINGS INC
5375 Medpace Way
Cincinnati OHIO 45227 US
CEO: August J. Troendle
Employees: 5900
Phone: 13026587581
MEDPACE HOLDINGS INC / MEDP FAQ
What does MEDP do?
Medpace Holdings, Inc. engages in the provision of outsourced clinical development services to the biotechnology, pharmaceutical, and medical device industries. The company is headquartered in Cincinnati, Ohio and currently employs 5,900 full-time employees. The company went IPO on 2016-08-11. The firm partners with pharmaceutical, biotechnology, and medical device companies in the development and execution of clinical trials. The Company’s drug development services focus on full-service Phase I-IV clinical development services and include development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support. The firm also provides bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. The Company’s operations are principally based in North America, Europe, and Asia.
Can you provide the latest stock price for MEDPACE HOLDINGS INC?
The current stock price of MEDP is 428.03 USD. The price increased by 2.88% in the last trading session.
Does MEDP stock pay dividends?
MEDP does not pay a dividend.
What is the ChartMill rating of MEDPACE HOLDINGS INC stock?
MEDP has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 7 out of 10.
What is the Price/Earnings (PE) ratio of MEDPACE HOLDINGS INC (MEDP)?
The PE ratio for MEDPACE HOLDINGS INC (MEDP) is 27.98. This is based on the reported non-GAAP earnings per share of 15.3 and the current share price of 428.03 USD.
What is the employee count for MEDP stock?
MEDPACE HOLDINGS INC (MEDP) currently has 5900 employees.
Can you provide the ownership details for MEDP stock?
You can find the ownership structure of MEDPACE HOLDINGS INC (MEDP) on the Ownership tab.